NEW YORK (GenomeWeb) – The University of Maryland School of Medicine announced it has been awarded a four-year, $3.7 million grant from the National Institutes of Health to develop a personalized medicine program for the diagnosis and treatment of monogenic diabetes.

The National Human Genome Research Institute and the Implementing Genomics in Practice network is providing the funding for the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.